←
Daniel Dickstein114 posts
Daniel Dickstein avatar

Daniel Dickstein

@DanielDickstein

Saying nothing is saying something.

◷ Joined May 2023▧ 10 Photos and videos
ASTRO avatar
⟳ Daniel Dickstein retweeted
ASTRO@ASTRO_org·8 Apr 2025

The 2025 Virtual Annual Refresher Course starts tomorrow! 📣 Nicholas G. Zaorsky, MD, MS invites you to join him for his session on April 11. Register today ➡️ ow.ly/hgiz50VwBjB @NicholasZaorsky

0:39
Paul Nguyen avatar
⟳ Daniel Dickstein retweeted
Paul Nguyen@DrPaulNguyen·6 Apr 2025

Hope to see everyone virtually at the 2025 @ASTRO_org Refresher Meeting this Wednesday-Friday for the latest updates in every disease site, econtouring sessions, and special radbio/physics talks from the comfort of your own home!!

ASTRO@ASTRO_org4 Apr 2025

Paul L. Nguyen, MD, MBA, FASTRO, Program Chair, shares why you should join him in participating in the 2025 Virtual Annual Refresher Course. Register now to get a comprehensive review of the best practices & emerging trends for the major disease sites! 📣 astro.org/meetings-and-educa…

1:02
ARS ROCKET🚀 avatar
⟳ Daniel Dickstein retweeted
ARS ROCKET🚀@ArsRocket·3 Apr 2025

Dr. @DanielDickstein sharing his important work advocating for tailoring treatments and physician-patient interactions for gender and sexual minority patients in the field of radiation oncology and beyond 🏳️‍🌈🏳️‍⚧️ @RadiumSociety

Post attachment
Alexander Rühle avatar
⟳ Daniel Dickstein retweeted
Alexander Rühle@RuehleAlex·26 Dec 2024

Our international study regarding cisplatin tolerability in older pts w/ HNSCC receiving CRT is online: ➡️53% achieved ≥200 mg/m² cisplatin ➡ Models (GLM, SVM, RFM) trained to predict cisplatin tolerability ➡ Key predictors: p16, hemoglobin, CRP, eGFR t1p.de/qdh5o

Sumanta K. Pal, MD, FASCO avatar
⟳ Daniel Dickstein retweeted
Sumanta K. Pal, MD, FASCO@montypal·8 Nov 2024

So grateful to @ShuchiGulati & @ConquerCancerFd for the opportunity to join this terrific panel w @tmprowell, #DrAmyPeterson & #DrChrisKanakry, representing perspectives from the @US_FDA, #industry, @theNCI & (my role!) #academic medicine. Great q's from @CliffordHudis. Was an amazing evening that began by positioning @ASCO leaders (incl @lynn_schuchter @SandraSwainMD #DrMargaretTempero @BurrisSkip & so many more!) w the next generation of #oncology leaders (@ShuchiGulati @JadChahoud @thenasheffect @rmelias2 @DanielHaldarMD @DanielDickstein to name a few!) for open discussion.

Post attachment

Dr. @CliffordHudis kickstarting a very informative packed session at the @ASCO @ConquerCancerFd career development retreat with an expert panel to talk about establishing collaborative relationships with industry and learn the nuances of FDA, NCI early on. @tmprowell @montypal #Dr.AmyPeterson #Dr.ChristopherKanakry

Post attachmentPost attachment
Conquer Cancer, the ASCO Foundation avatar
⟳ Daniel Dickstein retweeted
Conquer Cancer, the ASCO Foundation@ConquerCancerFd·8 Nov 2024

From inspirational speakers to in-person learning and brainstorming, the 2024 Grants and Awards Scientific and Career Development Retreat was a great success! Thanks to all attendees and board members who traveled to be together and share their knowledge at @ASCO HQ!

Post attachment